Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
Aron's father has been prescribed an oral hypoglycemic drug. Such drugs act:
A. As an insulin replacement.
Oral hypoglycemic drugs are not used as insulin replacements. Insulin replacement is usually achieved through the administration of insulin injections or insulin pumps. These devices deliver the hormone directly into the body to help regulate blood sugar levels, especially in individuals with type 1 diabetes or severe type 2 diabetes where insulin production is significantly impaired. Oral hypoglycemic drugs, on the other hand, work by different mechanisms and are primarily used for type 2 diabetes management.
B. To reduce insulin resistance.
Many oral hypoglycemic drugs, such as metformin and thiazolidinediones, work by reducing insulin resistance. Insulin resistance is a condition where the body's cells do not respond effectively to insulin, leading to elevated blood sugar levels. By improving the body's sensitivity to insulin, these drugs help lower blood sugar levels and improve glucose uptake by the cells. This mechanism is crucial for managing type 2 diabetes, where insulin resistance is a significant issue.
C. To prevent the formation of glucose.
Some oral hypoglycemic drugs, like metformin, do help in reducing glucose production by the liver. However, saying that these drugs "prevent" the formation of glucose is not entirely accurate. These drugs can inhibit gluconeogenesis, the process by which the liver produces glucose, thereby helping to lower blood sugar levels. However, this is only one aspect of their action, and they are not solely classified based on this mechanism.
D. To decrease the body's need for glucose in body cells.
Decreasing the body's need for glucose in body cells is not a primary action of oral hypoglycemic drugs. These medications aim to regulate blood glucose levels by improving insulin sensitivity, reducing glucose production in the liver, and sometimes increasing insulin secretion by the pancreas. The goal is to ensure that glucose is effectively utilized by the body's cells and that blood sugar levels are kept within a healthy range.
This question is an excerpt from Nurse Dive's nursing test bank - Ati pathophisiology proctored exam. Take the full exam now
Full Explanation
Choice A reason: Oral hypoglycemic drugs are not used as insulin replacements. Insulin replacement is usually achieved through the administration of insulin injections or insulin pumps. These devices deliver the hormone directly into the body to help regulate blood sugar levels, especially in individuals with type 1 diabetes or severe type 2 diabetes where insulin production is significantly impaired. Oral hypoglycemic drugs, on the other hand, work by different mechanisms and are primarily used for type 2 diabetes management.
Choice B reason: Many oral hypoglycemic drugs, such as metformin and thiazolidinediones, work by reducing insulin resistance. Insulin resistance is a condition where the body's cells do not respond effectively to insulin, leading to elevated blood sugar levels. By improving the body's sensitivity to insulin, these drugs help lower blood sugar levels and improve glucose uptake by the cells. This mechanism is crucial for managing type 2 diabetes, where insulin resistance is a significant issue.
Choice C reason: Some oral hypoglycemic drugs, like metformin, do help in reducing glucose production by the liver. However, saying that these drugs "prevent" the formation of glucose is not entirely accurate. These drugs can inhibit gluconeogenesis, the process by which the liver produces glucose, thereby helping to lower blood sugar levels. However, this is only one aspect of their action, and they are not solely classified based on this mechanism.
Choice D reason: Decreasing the body's need for glucose in body cells is not a primary action of oral hypoglycemic drugs. These medications aim to regulate blood glucose levels by improving insulin sensitivity, reducing glucose production in the liver, and sometimes increasing insulin secretion by the pancreas. The goal is to ensure that glucose is effectively utilized by the body's cells and that blood sugar levels are kept within a healthy range.
Similar Questions
Tumor markers are substances that may be detected in cells or body fluids and can provide clues to the presence, extent, and treatment response of certain neoplasms. What is an example of a tumor marker?
A. CA125
CA125, also known as Cancer Antigen 125, is a protein that is often elevated in ovarian cancer. It is used as a tumor marker to monitor treatment response and detect recurrence in patients with ovarian cancer. While CA125 can also be elevated in other conditions, it is most commonly associated with ovarian cancer and is a valuable tool in the management of this disease.
B. H&H levels
H&H levels refer to hemoglobin and hematocrit levels, which are measures of red blood cells in the blood. While these levels can provide important information about a patient's overall health and can be affected by various conditions, they are not specific tumor markers used to detect or monitor cancer.
C. Vitamin D levels
Vitamin D levels are important for bone health and overall well-being, but they are not used as tumor markers. Vitamin D deficiency or excess can have various health implications, but it does not provide specific information about the presence or progression of cancer.
D. Amylase levels
Amylase levels are enzymes that help digest carbohydrates. Elevated amylase levels can indicate pancreatic issues, such as pancreatitis, but they are not used as tumor markers for cancer detection or monitoring. Amylase levels are more relevant to gastrointestinal and pancreatic health rather than oncology.
Full Explanation
Choice A reason: CA125, also known as Cancer Antigen 125, is a protein that is often elevated in ovarian cancer. It is used as a tumor marker to monitor treatment response and detect recurrence in patients with ovarian cancer. While CA125 can also be elevated in other conditions, it is most commonly associated with ovarian cancer and is a valuable tool in the management of this disease.
Choice B reason: H&H levels refer to hemoglobin and hematocrit levels, which are measures of red blood cells in the blood. While these levels can provide important information about a patient's overall health and can be affected by various conditions, they are not specific tumor markers used to detect or monitor cancer.
Choice C reason: Vitamin D levels are important for bone health and overall well-being, but they are not used as tumor markers. Vitamin D deficiency or excess can have various health implications, but it does not provide specific information about the presence or progression of cancer.
Choice D reason: Amylase levels are enzymes that help digest carbohydrates. Elevated amylase levels can indicate pancreatic issues, such as pancreatitis, but they are not used as tumor markers for cancer detection or monitoring. Amylase levels are more relevant to gastrointestinal and pancreatic health rather than oncology.
There are 2 types of parenteral nutrition, Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN). TPN must be administered using:
A. NGT
NGT (nasogastric tube) is used for enteral feeding, not parenteral nutrition. Enteral feeding involves delivering nutrients directly to the stomach or small intestine, bypassing the need for eating. This method is suitable for patients who have a functioning digestive system but cannot eat orally. Parenteral nutrition, on the other hand, involves delivering nutrients directly into the bloodstream.
B. Orally
Oral administration of nutrition involves consuming food or nutrients by mouth. This method is suitable for individuals who can eat and digest food normally. Parenteral nutrition bypasses the digestive system altogether and delivers nutrients directly into the bloodstream, making oral administration inappropriate for TPN.
C. Central Line
Central Line is the correct answer because Total Parenteral Nutrition (TPN) requires delivery of nutrients directly into a central vein, typically the superior vena cava. This is because TPN solutions are highly concentrated and can irritate smaller veins, leading to complications such as phlebitis. A central line allows for the safe administration of TPN, ensuring that the high osmolarity solution is rapidly diluted by the large volume of blood in the central veins.
D. Peripheral line
Peripheral line administration is used for Peripheral Parenteral Nutrition (PPN), not TPN. PPN can be delivered through a peripheral vein because it is less concentrated than TPN. Using a peripheral line for TPN is not appropriate due to the risk of complications from the high osmolarity of the TPN solution.
Full Explanation
Choice A reason: NGT (nasogastric tube) is used for enteral feeding, not parenteral nutrition. Enteral feeding involves delivering nutrients directly to the stomach or small intestine, bypassing the need for eating. This method is suitable for patients who have a functioning digestive system but cannot eat orally. Parenteral nutrition, on the other hand, involves delivering nutrients directly into the bloodstream.
Choice B reason: Oral administration of nutrition involves consuming food or nutrients by mouth. This method is suitable for individuals who can eat and digest food normally. Parenteral nutrition bypasses the digestive system altogether and delivers nutrients directly into the bloodstream, making oral administration inappropriate for TPN.
Choice C reason: Central Line is the correct answer because Total Parenteral Nutrition (TPN) requires delivery of nutrients directly into a central vein, typically the superior vena cava. This is because TPN solutions are highly concentrated and can irritate smaller veins, leading to complications such as phlebitis. A central line allows for the safe administration of TPN, ensuring that the high osmolarity solution is rapidly diluted by the large volume of blood in the central veins.
Choice D reason: Peripheral line administration is used for Peripheral Parenteral Nutrition (PPN), not TPN. PPN can be delivered through a peripheral vein because it is less concentrated than TPN. Using a peripheral line for TPN is not appropriate due to the risk of complications from the high osmolarity of the TPN solution.
What is the primary risk factor for colon cancer?
A. Alcohol consumption
While alcohol consumption is a known risk factor for colon cancer, it is not considered the primary risk factor. Excessive alcohol intake can increase the risk of developing colorectal cancer, but its impact is less significant compared to age.
B. Smoking
Smoking is another risk factor for colon cancer, and long-term tobacco use has been linked to an increased risk of developing colorectal cancer. However, it is not the primary risk factor. Smoking primarily affects the lungs but also has systemic effects that can contribute to various cancers, including colorectal cancer.
C. Chronic inflammatory
Chronic inflammatory conditions, such as inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, can increase the risk of colon cancer. Chronic inflammation can lead to cellular changes and damage in the colon, which may eventually result in cancer. However, age remains the most significant risk factor.
D. Age
Age is the primary risk factor for colon cancer. The risk of developing colorectal cancer increases significantly with age, with the majority of cases occurring in individuals over the age of 50. As people age, the likelihood of genetic mutations and cellular damage accumulates, increasing the risk of cancer development.
Full Explanation
Choice A reason: While alcohol consumption is a known risk factor for colon cancer, it is not considered the primary risk factor. Excessive alcohol intake can increase the risk of developing colorectal cancer, but its impact is less significant compared to age.
Choice B reason: Smoking is another risk factor for colon cancer, and long-term tobacco use has been linked to an increased risk of developing colorectal cancer. However, it is not the primary risk factor. Smoking primarily affects the lungs but also has systemic effects that can contribute to various cancers, including colorectal cancer.
Choice C reason: Chronic inflammatory conditions, such as inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, can increase the risk of colon cancer. Chronic inflammation can lead to cellular changes and damage in the colon, which may eventually result in cancer. However, age remains the most significant risk factor.
Choice D reason: Age is the primary risk factor for colon cancer. The risk of developing colorectal cancer increases significantly with age, with the majority of cases occurring in individuals over the age of 50. As people age, the likelihood of genetic mutations and cellular damage accumulates, increasing the risk of cancer development.